136 related articles for article (PubMed ID: 17979506)
1. Expression of CYP2W1 in colon tumors: regulation by gene methylation.
Gomez A; Karlgren M; Edler D; Bernal ML; Mkrtchian S; Ingelman-Sundberg M
Pharmacogenomics; 2007 Oct; 8(10):1315-25. PubMed ID: 17979506
[TBL] [Abstract][Full Text] [Related]
2. Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1.
Karlgren M; Gomez A; Stark K; Svärd J; Rodriguez-Antona C; Oliw E; Bernal ML; Ramón y Cajal S; Johansson I; Ingelman-Sundberg M
Biochem Biophys Res Commun; 2006 Mar; 341(2):451-8. PubMed ID: 16426568
[TBL] [Abstract][Full Text] [Related]
3. Colon cancer-specific cytochrome P450 2W1 converts duocarmycin analogues into potent tumor cytotoxins.
Travica S; Pors K; Loadman PM; Shnyder SD; Johansson I; Alandas MN; Sheldrake HM; Mkrtchian S; Patterson LH; Ingelman-Sundberg M
Clin Cancer Res; 2013 Jun; 19(11):2952-61. PubMed ID: 23589180
[TBL] [Abstract][Full Text] [Related]
4. Developmental regulation and induction of cytochrome P450 2W1, an enzyme expressed in colon tumors.
Choong E; Guo J; Persson A; Virding S; Johansson I; Mkrtchian S; Ingelman-Sundberg M
PLoS One; 2015; 10(4):e0122820. PubMed ID: 25844926
[TBL] [Abstract][Full Text] [Related]
5. Expression of cytochrome P450 arachidonic acid epoxygenase 2J2 in human tumor tissues and cell lines.
Jiang JG; Fu XN; Chen CL; Wang DW
Ai Zheng; 2009 Feb; 28(2):93-6. PubMed ID: 19550113
[TBL] [Abstract][Full Text] [Related]
6. The expression of CYP2W1: a prognostic marker in colon cancer.
Stenstedt K; Hallstrom M; Johansson I; Ingelman-Sundberg M; Ragnhammar P; Edler D
Anticancer Res; 2012 Sep; 32(9):3869-74. PubMed ID: 22993331
[TBL] [Abstract][Full Text] [Related]
7. Tumour-specific expression of CYP2W1: its potential as a drug target in cancer therapy.
Karlgren M; Ingelman-Sundberg M
Expert Opin Ther Targets; 2007 Jan; 11(1):61-7. PubMed ID: 17150034
[TBL] [Abstract][Full Text] [Related]
8. Human Cytochrome P450 2W1 Is Not Expressed in Adrenal Cortex and Is Only Rarely Expressed in Adrenocortical Carcinomas.
Nolé P; Duijndam B; Stenman A; Juhlin CC; Kozyra M; Larsson C; Ingelman-Sundberg M; Johansson I
PLoS One; 2016; 11(9):e0162379. PubMed ID: 27598485
[TBL] [Abstract][Full Text] [Related]
9. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms and haplotype structures of the human CYP2W1 gene in a Japanese population.
Hanzawa Y; Sasaki T; Mizugaki M; Ishikawa M; Hiratsuka M
Drug Metab Dispos; 2008 Feb; 36(2):349-52. PubMed ID: 17998294
[TBL] [Abstract][Full Text] [Related]
11. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
Zhong S; Tang MW; Yeo W; Liu C; Lo YM; Johnson PJ
Clin Cancer Res; 2002 Apr; 8(4):1087-92. PubMed ID: 11948118
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 2W1 (CYP2W1) - ready for use as the biomarker and drug target for cancer?
Pan Y; Ong EC
Xenobiotica; 2017 Oct; 47(10):923-932. PubMed ID: 27690753
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer-specific cytochrome P450 2W1: intracellular localization, glycosylation, and catalytic activity.
Gomez A; Nekvindova J; Travica S; Lee MY; Johansson I; Edler D; Mkrtchian S; Ingelman-Sundberg M
Mol Pharmacol; 2010 Dec; 78(6):1004-11. PubMed ID: 20805301
[TBL] [Abstract][Full Text] [Related]
14. Genistein increases gene expression by demethylation of WNT5a promoter in colon cancer cell line SW1116.
Wang Z; Chen H
Anticancer Res; 2010 Nov; 30(11):4537-45. PubMed ID: 21115903
[TBL] [Abstract][Full Text] [Related]
15. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA
Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622
[TBL] [Abstract][Full Text] [Related]
16. [Methylation of mismatch repair gene (MMR) in primary hepatocellular carcinoma].
Zhang CJ; Li HM; Yau LM; Suen KW; Zhou GY; Yu F; Liew CT
Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):433-6. PubMed ID: 15498213
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of hTERT promoter in hepatocellular carcinomas.
Iliopoulos D; Satra M; Drakaki A; Poultsides GA; Tsezou A
Int J Oncol; 2009 Feb; 34(2):391-9. PubMed ID: 19148473
[TBL] [Abstract][Full Text] [Related]
18. Methylation and regulation of expression of different retinoic acid receptor beta isoforms in human colon cancer.
Youssef EM; Estecio MR; Issa JP
Cancer Biol Ther; 2004 Jan; 3(1):82-6. PubMed ID: 14726683
[TBL] [Abstract][Full Text] [Related]
19. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
[TBL] [Abstract][Full Text] [Related]
20. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW
World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]